ScholarWorks@Korea University College of Medicine: So, Kyeong A

Detailed Information

So, Kyeong A (소경아)

Guro Hospital (Department of Obstetrics and Gynecology, Guro Hospital)

Research Area

Tel 02-2626-3168
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Human papillomavirus:7||ovarian cancer:4||Cervical intraepithelial neoplasia:4||Prognosis:3||Ovarian cancer:3||Cervical Intraepithelial Neoplasia:3||Immunohistochemistry:3||Genotype:3||Endometrial cancer:3||cervical intraepithelial neoplasia:3||Ovarian neoplasms:2||Cytology:2||Fertility:2||epithelialmesenchymal transition:2||Papillomaviridae:2||gynecologic cancer:2||Pregnancy:2||Menopause:2||Adenocarcinoma:2||Viral load:2||Cervical cancer:2||cervical cancer:2||Mucinous borderline tumor:2||paclitaxelresistance:2||Cervical Cancer:2||laparoscopically assisted vaginal hysterectomy:2||Ovarian carcinoma:2||Ovarian malignancy:2||Cy5:1||DNA Methylation:1||DNA microarray:1||Delphinidin:1||Diagnosis:1||Dualphase:1||EGFR:1||EQ5D5L:1||Endometrial Cancer:1||Endometrial Neoplasms:1||Epidemiology:1||Epigenetics:1||FGFR1/FRS2 signaling pathway:1||Fertility preservations:1||Fluorescent intensity:1||Genotyping:1||Gynecologic Neoplasm:1||Gynecologic Surgery:1||HER2:1||HPV:1||HPV 16:1||HPV 18:1||HealthRelated Quality of Life:1||Hematocolpos:1||Highrisk HPV:1||Human Papilloma Virus:1||Human papilloma virus:1||Human papillomavirus DNA tests:1||Hypogastric Artery:1||Hysterectomy:1||Immune checkpoint inhibitors:1||Imperforate hymen:1||Informed Consent:1||Invasion:1||Laparoscopy:1||Leiomyosarcoma:1||Leukocytosis:1||Lymph Node Dissection:1||Lymph node metastasis:1||Mature cystic teratoma:1||Medical Ethics:1||Meta analysis:1||Microarray:1||Microbiota:1||Migration:1||Minimally invasive surgery:1||Mismatch repair deficiency:1||Mycoplasma genitalium:1||Mycoplasma hominis:1||Overall survival:1||Ozone:1||Paraneoplastic necrotizing myopathy:1||PeutzJeghers syndrome:1||Placenta Increta:1||Positron emission tomography:1||Predictive Factors:1||Progestin:1||Progestins:1||Programmed Cell Death1:1||Programmed cell death ligand 1:1||Pseudomyxoma peritonei:1||Rectum:1||Recurrence:1||Recurrencefree survival:1||Recurrences:1||Regression Analysis:1||Retention index:1||Rh immune globulin:1||Robot Surgery:1||SDS coating:1||Sacral agenesis:1||Seeplex HPV4A ACE:1||Self collection:1||Semen analysis:1||Sentinel Lymph Node Biopsy:1||Sexually transmitted disease:1||Silver in situ hybridization:1||Smoking:1||Specimen handling:1||Standardized uptake value:1||TWIST:1||Trachelectomy:1||Trichostatin A:1||Ureaplasma urealyticum:1||Urine specimen collection:1||Uterine Cervical Neoplasms:1||Uterine Neoplasm:1||Uterine cervical neoplasm:1||Uterine cervical neoplasms:1||Uterine neoplasms:1||Vaginal intraepithelial neoplasia:1||Vaginal smear:1||alloimmunization:1||antiD:1||artificial intelligence:1||benign gynecologic disease:1||cancer:1||cervicography:1||cervicovaginal incision:1||chronic pain:1||conization:1||dacomitinib:1||deguelin:1||diabetic nephropathy:1||education:1||endocervical glandular involvement:1||endometrial carcinoma:1||endometriosis:1||geriatric oncology:1||gynecologic cancers:1||hysterectomy:1||immunohistochemistry:1||inflammation:1||interleukin6:1||invasion:1||macrophages:1||metachronous malignancies:1||metastasis:1||monocyte chemoattractant peptide (MCP)1:1||multiple primary malignant tumors:1||neuroinflammation:1||paclitaxel resistance:1||panEGFR inhibitor:1||partial D:1||passive smoking:1||peritoneal reflection:1||podocyte:1||reactive oxygen species:1||recurrence:1||resident participation:1||resident training:1||retinoid:1||rhesus blood group system:1||sensitization:1||silver in situ hybridization:1||singleport laparoscopy:1||smoking:1||streptozotocin:1||surgical outcomes:1||surgical training:1||surgical treatment:1||survival outcome:1||synchronous malignancies:1||tephrosin:1||tissue injuries:1||5 'aza2 'deoxycytidine:1||vaginal hysterectomy:1||AKT:1||Abdominal pain:1||Adolescent:1||Akt:1||Amenorrhea:1||Anorectal malformation:1||Atypical endometriosis:1||Balloon Occlusion:1||Brainderived neurotrophic factor (BDNF):1||CMET:1||CD133:1||CXC chemokine ligand 11:1||Cancer stem cell:1||Case report:1||Cervical Cancer Screening:1||Cervical Cytology:1||Cervista HPV 16/18:1||Cervista HPV HR:1||Chemotherapy:1||Chlamydia trachomatis:1||Choriocarcinoma:1||Clear cell carcinoma:1||Clinical Practice Pattern:1||Colposcopy:1||Conization:1||Conservative treatment:1||Currarino syndrome:1||

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE